Sign in

Bella Goren

About Bella Goren

Independent director aged 65; joined Marriott’s board in 2022. She serves as Audit Committee Chair and is a member of the Nominating and Corporate Governance Committee; designated an Audit Committee Financial Expert. Former CFO of American Airlines, Inc. and AMR Corporation (2010–2013), bringing deep financial expertise and global travel industry experience. Current public board: GE Aerospace; prior five-year public boards: Gap, Inc. and LyondellBasell Industries .

Past Roles

OrganizationRoleTenureNotes
American Airlines, Inc. & AMR CorporationChief Financial Officer2010–2013Led finance, investor relations, human resources, revenue management, and marketing; large-scale operations oversight .
American AirlinesSVP, Customer Relationship Marketing2006–2010Led loyalty programs, technology/data analytics, and customer service organizations .
AMR ServicesPresidentNot disclosedProgression through finance and global operational roles .
American AirlinesVP, Interactive Marketing; VP, Asia Pacific Operations; VP, Customer Services PlanningNot disclosedGlobal strategy implementation and operational leadership .

External Roles

OrganizationRoleTenureCommittees/Impact
GE AerospaceDirectorCurrentPublic company directorship .
Gap, Inc.DirectorPast 5 yearsPublic company directorship .
LyondellBasell IndustriesDirectorPast 5 yearsPublic company directorship .
MassMutual Financial GroupBoard of DirectorsCurrentPrivate mutual company board .
SMU Lyle School of EngineeringExecutive Board MemberCurrentAcademic governance role .
UT Austin Cockrell School of EngineeringAdvisory Board MemberCurrentAcademic advisory role .

Board Governance

  • Independence: Independent director; compliant with governance limits on total public boards and audit committee memberships; all members of Audit, HRCC, and NCGC are independent; Goren, Henderson, and Lewis designated Audit Committee Financial Experts .
  • Committee assignments: Audit (Chair), Nominating and Corporate Governance (Member) .
  • Audit Committee activity: 7 meetings held in FY2024; oversight includes accounting, internal control, external auditor, internal audit, related party transactions, compliance, risk management (including safety/security), and derivatives policy .
  • Attendance: Board met 4 times in FY2024; no current director or nominee attended fewer than 75% of Board and committee meetings; all 12 nominees attended the 2024 annual meeting .
  • Stakeholder engagement: Stockholders may communicate with the Audit Committee and non-employee directors via [email protected] or mail; Board directs procedures and retains advisors as needed .
  • Audit Committee report: Approved inclusion of audited FY2024 financials in Form 10-K; confirmed auditor independence communications per PCAOB/SEC requirements .

Fixed Compensation

ComponentDetail2024 Amount (USD)
Board retainer (cash)Annual cash retainer$100,000 .
Audit Committee Chair fee (cash)Annual chair fee$35,000 .
Cash fees totalFees earned or paid in cash$135,000 .
All Other CompensationPerquisites and Company contributions to EDC where applicable$22,892 .
Director compensation policyTargeted at 50th percentile vs cross-industry surveys and custom peer group; quarterly retainer payments; deferral options via Stock Plans and EDCPolicy summary (no dollar value) .

Notes:

  • Directors may elect to defer cash fees into stock units under Stock Plans and/or EDC; or elect SARs in lieu of cash with 10-year term and grant-date FMV exercise price .

Performance Compensation

Award TypeGrant DateShares/UnitsGrant FMV/PriceVesting/PerformanceDistribution
Deferred Share Award (DS)May 13, 2024837 shares$200,010 grant-date fair value; $238.96 per-share (avg high/low)Vests daily pro‑rata over the director’s term; no performance conditions; no dividend equivalents or voting until distributionLump sum after separation unless elected for 1-year post-grant or 1–10 annual installments .

No director PSUs or performance metrics apply to non-employee director equity grants; awards are time-based to align with service periods .

Other Directorships & Interlocks

CompanyRelationship to MAR businessPotential Interlock/Conflict Assessment
GE AerospaceAerospace OEMNo direct lodging conflict; standard cross-industry directorship .
Gap, Inc.Retail apparelNo direct lodging conflict .
LyondellBasell IndustriesChemicalsNo direct lodging conflict .
MassMutualInsurance/financial services (mutual)No direct lodging conflict .

Related party oversight: Audit Committee reviews/approves related person transactions >$120,000; policy includes predefined limited categories and internal Corporate Growth Committee pre-approval, with criteria for arm’s-length terms .
Audit Committee specifically oversees policies/procedures related to related party transactions and conflicts of interest .

Expertise & Qualifications

  • Deep financial expertise and global travel industry background spanning ~30 years; led complex global strategies; finance functions; customer technology and data analytics; loyalty programs; HR; revenue management; investor relations; marketing; and large-scale international operations .
  • Strategic and governance experience from service on public, private, and non-profit boards; contributes to Audit leadership and board deliberations .

Equity Ownership

HolderShares Beneficially Owned (as of Mar 1, 2025)Percent of ClassVested DS UnitsUnvested DS/Units
Isabella D. Goren3,091*2,788303 .

Ownership guidelines: Non-employee directors must hold stock or vested stock units equal to 3x combined annual cash and stock retainers (roughly 9x cash retainer) within five years of joining; must retain 50% of net after-tax shares from equity awards until compliance; all directors with ≥5 years have met the goal .
Hedging/pledging: Directors prohibited from hedging or derivative transactions; independent directors and executive officers prohibited from holding stock in margin accounts and pledging as collateral; no pledging approval requests in 2024 .
Section 16 compliance: All Reporting Persons complied for FY2024 except late filings by David S. Marriott and Deborah M. Harrison due to administrative errors; no late filings noted for Goren .

Governance Assessment

  • Board effectiveness: As Audit Committee Chair in a year with 7 Audit meetings, Goren is central to financial reporting oversight, auditor independence, internal controls, compliance, and related-party policy governance—supports investor confidence in audit quality and disclosure integrity .
  • Independence and expertise: Independent status with Audit Committee Financial Expert designation strengthens oversight of accounting and controls; governance limits on outside boards/audit committees enforced company-wide .
  • Alignment: Standard cash retainer plus time-based DS grants; robust director ownership guidelines and anti-hedging/anti-pledging policies enhance alignment and reduce risk of misaligned incentives .
  • Attendance and engagement: No directors below 75% attendance; structured channels for stockholder communications with committees indicate active governance engagement .
  • RED FLAGS: None disclosed specific to Goren—no related-party transactions, pledging, hedging, or delinquent Section 16 filings noted; perquisites present but modest (~$22.9k) and disclosed; equity grants are time-based without performance metrics (typical for directors) .